Wellcome-Wolfson Institute of Experimental Medicine, Queen’s University Belfast, UK
What are we doing to tackle lung infections pandemic?
Director of Isotope Chemistry, AstraZeneca Pharmaceuticals
A rational approach to the development of radioligands and PET ligands for drug development
Professor, Complutense University (Madrid)
"Characterization of metabolic reprogramming in Pulmonary Hypertension"
SNSF Professor, Department of Chemistry, University of Zurich
"PET radiotracers for imaging oncogenic signalling pathways"
Radiopharmacy Unit Director Clínica Universidad de Navarra
"Rebutting paradigms in FDG metabolism"
Head of Translational Laboratory for Cardiovascular Imaging and Therapy, CNIC
"Role of CMR in post-myocardial infarction tissues characterization"
Cardiologist specialized in Cardiac Imaging, CNIC
"Quantitative perfusion by CMR"
Senior Director Neuroscience Experimental Medicine, Janssen Research and Development
"PET ligand discovery efforts for CNS drug development: why and when does it matter"
Biomedical MRI/ MoSAIC, University of Leuven
"Multimodal and multiparametric imaging for diagnosis and follow up of infectious diseases"
Assistant professor, VU University Medical Center, Amsterdam
“Preclinical and clinical immuno-PET imaging in oncology”
Professor at "Sapienza" University of Rome and University Medical Center Groningen, The Netherlands
"Animal models and bacteria imaging"